Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Working in partnership to share University of Oxford research with local communities in Banbury

Black and white lines on a floor creating a visual illusion of a black hole © Medium / Jacqueline Pumphrey

The ‘Your Amazing Brain: A User’s Guide’ exhibition is the result of a close collaboration between Banbury Museum & Gallery and the Wellcome Centre for Integrative Neuroimaging, University of Oxford. Funded by the Wellcome Trust.

A labyrinth of puzzles and illusions

Stepping into the exhibition at Banbury Museum & Gallery is a bit like stepping into the Hall of Mirrors at the Palace of Versailles. A kaleidoscope of colours and patterns assaults your senses. The overall effect is momentarily disorientating and simultaneously intriguing. Are those horizontal lines on that black and white tiled wall really straight? Why does the stripy floor look as though it’s got a massive hole in it? And what’s going on in the orange room with the pink slope that makes children look as tall as adults?

This almost psychedelic experience is just the start of a whole suite of illusory exhibits and puzzles that are fascinating visitors of all ages. The first part of the exhibition demonstrates how the shortcuts that your brain has learned in order to make sense of the world sometimes backfire, resulting in a confusing optical illusion. In a different zone, you can have a go at drawing a star reflected in a mirror (harder than it sounds); pick up two different sized cubes and work out which is heavier; and, for the brave, plunge your hand into covered boxes to feel what is inside. These activities provoke curiosity about the brain’s role in our senses and emotions.

Read more about the exhibition in a Medium article, written by Jacqueline Pumphrey, Communications & Public Engagement Manager in the Nuffield Department of Clinical Neurosciences

Similar stories

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8 October 2026.

Wearable chest patch could support hospital-level care at home, study finds

Researchers in Oxford have shown that wearable chest patches can be used to effectively monitor vital signs in many acutely unwell patients receiving hospital-level care in their own homes.

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Phase I clinical study of ChAdOx1 BDBV vaccine launches in Uganda

The Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM Uganda Research Unit) has launched a Phase I clinical study evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV), in partnership with the University of Oxford.

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.